Thursday, February 14, 2013

• Clovis Oncology to Announce Fourth Quarter/Year End 2012 Financial Results and Host Webcast Conference Call on February 28Business Wire (Thu, Feb 14)

Tuesday, January 22, 2013

• Celgene's Abraxane: Two Month Survival Boost In Pancreatic Cancer Trialat TheStreet (Tue, Jan 22)

Friday, January 18, 2013

• Colorado stocks: Prospect Global up 6.5%, Gevo up 5% as Dow, S&P hit 5-year highsat bizjournals.com (Fri, Jan 18)

Wednesday, January 9, 2013

• CLOVIS ONCOLOGY, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and ExhEDGAR Online (Wed, Jan 9)

Monday, January 7, 2013

• Clovis Oncology Announces 2013 Objectives and Financial GuidanceBusiness Wire (Mon, Jan 7)

Wednesday, January 2, 2013

• Clovis Oncology to Present at the 31st Annual J.P. Morgan Healthcare ConferenceBusiness Wire (Wed, Jan 2)
• 3 Biotech Stocks to Avoid in 2013at Motley Fool (Wed, Jan 2)

Thursday, December 27, 2012

• Colorado stocks: Array BioPharma up 4%; UQM down 17%at bizjournals.com (Thu, Dec 27)

Monday, December 17, 2012

• Colorado stocks: General Moly up 8%; heavy trading for Liberty Mediaat bizjournals.com (Mon, Dec 17)

Thursday, December 13, 2012

• Interesting Value Proposition Setback - PART IIat Motley Fool (Thu, Dec 13)
• Interesting Value Proposition Despite Setback - PART IIIat Motley Fool (Thu, Dec 13)

Thursday, December 6, 2012

• Why Clovis Oncology Is Poised to Plungeat Motley Fool (Thu, Dec 6)

Thursday, November 29, 2012

• Revlimid Ramp-Up, New Drug Launches Make Celgene a Buyat Motley Fool (Thu, Nov 29)

Monday, November 19, 2012

• This Week in Biotech: Part 2at Motley Fool (Mon, Nov 19)

Saturday, November 17, 2012

• 3 Horrendous Health-Care Stocks This Weekat Motley Fool (Sat, Nov 17)

Wednesday, November 14, 2012

• CLOVIS ONCOLOGY, INC. Files SEC form 10-Q, Quarterly ReportEDGAR Online (Wed, Nov 14)

Tuesday, November 13, 2012

• Clovis Gets Creamed After Cancer Drug Failureat Motley Fool (Tue, Nov 13)
• Why Clovis Oncology's Shares Were Decimatedat Motley Fool (Tue, Nov 13)
• CLOVIS ONCOLOGY, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and ExhibitsEDGAR Online (Tue, Nov 13)
• Clovis Oncology: This Treatment is Out of Reachat Wall St. Cheat Sheet (Tue, Nov 13)

Monday, November 12, 2012

• Movers roundup: Celgene, Clovis OncologyAP (Mon, Nov 12)
• Colorado stocks: AspenBio Pharma up 7%; Clovis Oncology down 42% on drug test failureat bizjournals.com (Mon, Nov 12)
• Clovis Oncology pancreatic cancer drug fails trial; stock divesat bizjournals.com (Mon, Nov 12)
• Clovis tumbles on pancreatic cancer drug failureAP (Mon, Nov 12)
• Midday Movers: BA, MSFT, GILD & Moreat CNBC (Mon, Nov 12)

Add CLVS News to My Yahoo!